Abbvie Inc Drug Patent Portfolio

Drug Patent Number Drug Patent Title Drug Patent Expiry Status


Abbvie Inc's Family Patents


Family Patents



Abbvie Inc Drug List

Given below is the complete list of Abbvie Inc's drugs and the patents protecting them.


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

AbbVie Increases Value by Over $24 Billion in Half a Year: Strategies for Investing in ABBV Stock - The Globe and Mail

27 Jun, 2025

Sales of Prescription Medications Expected to Reach $1.75 Trillion by 2030 Driven by GLP-1s: An Analysis - BioSpace

25 Jun, 2025

LLY or ABBV: Which Pharmaceutical Giant is the Superior Investment? - Yahoo Finance

20 Jun, 2025

AbbVie's migraine medication achieves primary objective in direct comparison with topiramate - AOL.com

18 Jun, 2025

See More